"In complete contrast over the last decades, we are measuring that healthcare budgets for U.S. employers will come in nearly three times lower than the Consumer Price Index this calendar year. Despite this historic occurrence, employer health costs are expected to increase 6.5[%] in 2023 due to economic inflation pressures," says Debbie Ashford, North America chief actuary for health solutions at Aon.

More than 4 in 10 prescription drug medicine users are concerned that drug spending will lead to bankruptcy or debt.

The new funding all came from existing investors. “Reinvesting in the company demonstrates confidence in our innovation," CathVision's CEO said about the news. 

Payers have been using rates agreed to by PCPs to justify underpaying specialists such as anesthesiologists, emergency physicians and, yes, radiologists.

Three major pharmacy names will have to fork over hundreds of millions of dollars to two Ohio counties for their roles in the opioid epidemic, a judge has ruled.

New investors for this funding round included Kaiser Permanente, a star athlete and social media personalities. 

The act is Biden’s third major piece of legislation to sign into law since the start of his term, and it accomplishes a healthcare task the Democrats have been wanting for years: enabling Medicare to negotiate prescription drug prices.

The new report, based on data from the U.S. Bureau of Labor Statistics, once again highlights the fact that cardiology is associated with high demand and high compensation in today's market.